CD80 and diabetes mellitus: As expected, mice treated with anti-CD80/86 Ab alone showed a delay in diabetes development but rapidly developed disease upon treatment cessation (Fig. 4c); analysis of blood samples confirmed a loss of Treg in these mice (Supplementary Fig. 2a).